Evidence map›Paper›PMID 17534603›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2007

Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2.

Daniel Scherer, Claudia Kiesecker, Martin Kulzer, Myriam Günth, Eberhard P Scholz, Sven Kathöfer, Dierk Thomas, Martin Maurer, Jörg Kreuzer, Alexander Bauer and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Beta-Adrenergic Activation of the Inward Rectifier KInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Influence of Continuous Training on Atrial Myocytes ICardiology research and practice · 2018
    Article
  8. Role of plasma membrane-associated AKAPs for the regulation of cardiac INaunyn-Schmiedeberg's archives of pharmacology · 2017
    Article
  9. Review
  10. Boosting the signal: Endothelial inward rectifier KMicrocirculation (New York, N.Y. : 1994) · 2017
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Cardiac adrenergic control and atrial fibrillation.Naunyn-Schmiedeberg's archives of pharmacology · 2010
    Review
  17. Cardiac strong inward rectifier potassium channels.Journal of molecular and cellular cardiology · 2010
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Daniel SchererDepartment of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Claudia Kiesecker
Martin Kulzer
Myriam Günth
Eberhard P Scholz
Sven Kathöfer
Dierk Thomas
Martin Maurer
Jörg Kreuzer
Alexander Bauer
Hugo A Katus
Christoph A Karle
Edgar Zitron
University Hospital Heidelberg · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

beta(3)-adrenoceptors have recently been shown to induce a complex modulation of intracellular signaling pathways including cyclic guanine monophosphate, cyclic adenosine monophosphate, nitric oxide, and protein kinases A and C. They are expressed in a broad variety of tissues including the myocardium, vascular smooth muscle, and endothelium. In those tissues, resting membrane potential is controlled mainly by inwardly rectifying potassium channels of the Kir2 family namely, Kir2.1 in the vascular smooth muscle, Kir2.1-2.3 in the myocardium, and Kir2.1-2.2 in the endothelium. In the present study, we investigated the possible modulation of Kir2 channel function by beta(3)-adrenoceptors in an expression system. Human-cloned beta(3)-adrenoceptors and Kir2.1 (KCNJ2), Kir2.2 (KCNJ12), and Kir2.3 (KCNJ4) channels were coexpressed in Xenopus oocytes, and currents were measured with double-microelectrode voltage clamp. Activation of beta(3)-adrenoceptors with isoproterenol resulted in markedly increased currents in Kir2.1 and in Kir2.2 potassium channels with EC50 values of 27 and 18 nM, respectively. In contrast, Kir2.3 currents were not modulated. Coapplication of specific inhibitors of protein kinase A (KT-5720) and calmodulin kinase II (KN-93) had no effects on the observed regulation in Kir2.1. However, coapplication of protein kinase C (PKC) inhibitors staurosporine and chelerythrine suppressed the observed effect. In Kir2.2, coapplication of KT-5720 reduced the effect of beta(3)-adrenoceptor activation. No differences in current increase after application of isoproterenol were observed between mutant Kir2.2 potassium channels lacking all functional PKC phosphorylation sites and Kir2.2 wild-type channels. In heteromeric Kir2.x channels, all types of heteromers were activated. The effect was most pronounced in Kir2.1/Kir2.2 and in Kir2.2/Kir2.3 channels. In summary, homomeric and heteromeric Kir2.x channels are activated by beta(3)-adrenoceptors via different protein kinase-dependent pathways: Kir2.1 subunits are modulated by PKC, whereas Kir2.2 is modulated by protein kinase A. In heteromeric composition, a marked activation of currents can be observed particularly with involvement of Kir2.2 subunits. This regulation may contribute to the hyperpolarizing effects of beta(3)-adrenoceptors in tissues that exhibit modulation by Kir2 channel function.

Indexed as

AnimalsCyclic AMP-Dependent Protein KinasesFemaleOocytesPatch-Clamp TechniquesPotassiumPotassium Channel BlockersPotassium Channels, Inwardly RectifyingProtein Kinase CReceptors, Adrenergic, beta-3Signal TransductionXenopus laevisCyclic AMP-Dependent Protein KinasesKCNJ4 protein, humanKir2.1 channelKir2.2 channelPotassiumPotassium Channel BlockersPotassium Channels, Inwardly RectifyingProtein Kinase CReceptors, Adrenergic, beta-3

Identifiers

PMID17534603
OpenAlexW2080104381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.